X-BONECUT
Financiado
Next generation robotic surgery robotic vision based safe endoscopic spine surg...
All surgical robotic solutions available in the market today are precise manipulators rather than robots, as none of them takes its own decisions nor does automatize any process. For surgical robotics to make the next paradigm cha...
All surgical robotic solutions available in the market today are precise manipulators rather than robots, as none of them takes its own decisions nor does automatize any process. For surgical robotics to make the next paradigm change, the ability for the robots to take their own decisions must be developed. To take their own decisions, they need to be aware of the environment where they are working. In other words: they need to have robotic eyes. This is exactly what Deneb Medical (DM) is developing with its X Platform. This surgical robotic platform approach enables multiple market applications, for which Deneb Medical has defined a product pipeline. The first product in this pipeline is DM’s X-BoneCut.
Today the most important surgical problem, is the elimination of surgical unintended damage. DM’s X-BoneCut will be a surgical robot tailored to perform endoscopic lumbar surgeries in a safe and fast way, eliminating the risk of surgical unintended damage to duramater (incidental durotomy) and nerves, reducing overall surgery time and with an easy learning curve. X-BoneCut will add to private and public health institutions up to 7B$ in value in EU and US, as it will help reduce total average direct costs to hospitals in 7B$.
DM’s business model is based on the development, manufacturing and sale of the robot and its disposable. The revenue model includes the sale to the distributor of a) the robotic system b) the disposable needed to perform surgeries with it and c) the robot’s maintenance contract. DM’s strategy is to install a big number of robots and supply the disposables, so the revenue portion of the disposable will increase throughout the years.
X-BoneCut is based on a DM’s already patented technology and DM knows no competitor that is developing a similar device with a similar functionality. Further DM is working on 3 additional patent applications that will help create stronger competitive advantages, not only for the short but also for the longer term.
ver más
Duración del proyecto: 30 meses
Fecha Inicio: 2019-10-11
Fecha Fin: 2022-04-30
Fecha Fin: 2022-04-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2022-04-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
3M€
Líder del proyecto
DENEB MEDICAL
1. actividades profesionales. 2. informática, telecomunicaciones y ofimática. 3. investigación, desarrollo e innovación. 4. actividades cien...
Perfil tecnológico
TRL
4-5
829K
Perfil tecnológico
TRL
4-5
829K